Evaluating the Effects of Tasimelteon vs Placebo on Sleep Disturbances in SMS

A new clinical study is investigating circadian rhythms and sleep disturbances in people with Smith-Magenis Syndrome to guide the development of a possible treatment.

Your child or dependent may qualify if:

• they have Smith-Magenis Syndrome
• they have sleeping problems

Qualified individuals will be compensated for their time and effort. Transportation will be provided at no cost.

ClincalTrials.gov Identifier: NCT02231008

For more information contact SMStrials@vandapharma.com or call toll-free: 844-366-2424.